Panth Infinity Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Panth Infinity Ltd is ₹ 11.08 as of 23 Oct 15:30 . The P/E Ratio of Panth Infinity Ltd is 9.1 as of March 2025 .The P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd is 0 as of March 2025 . The Market Cap of Panth Infinity Ltd is ₹ 16.99 crore as of March 2025 .The Market Cap of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2025 . The revenue of Panth Infinity Ltd for the Jun '26 is ₹ 59.3 crore as compare to the Mar '26 revenue of ₹ 59.85 crore. This represent the decline of -0.92% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Panth Infinity Ltd for the Jun '26 is ₹ 14.02 crore as compare to the Mar '26 ebitda of ₹ 21.78 crore. This represent the decline of -35.63% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Panth Infinity Ltd changed from ₹ 1.11 crore to ₹ 14.01 crore over 7 quarters. This represents a CAGR of 325.80% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Panth Infinity Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Panth Infinity Ltd

Panth Infinity Limited was initially incorporated as Synergy Bizcon Limited in April 1993.
Subsequently, Company was taken over by Jyoti Prakash Bapna in October, 1995 and the name of the Company was changed to Panth Infinity Limited upon issue of Fresh Certificate of Incorporation dated May 7, 2018 issued by the Registrar of Companies, Madhya Pradesh. Initially, the Company was providing consultancy services in the field of construction and real estate development.
In 1996, the company took up a project for residential housing with a proposed construction area of 5 lac sq ft at Neemuch on contract basis.
It came out with a public issue in Jul.'96 to finance the cost of the project. Company has been engaged in trading of diamond and precious stones for quite a few years now.
Incorporated in 1993, Company had seet a benchmark in the diamond trading business, It is coming up with a unique e-commerce platform.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Panth Infinity Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Panth Infinity Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Panth Infinity Ltd is 61 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Panth Infinity Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Panth Infinity Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Panth Infinity Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 24, 2026, the Panth Infinity Ltd stock price is INR ₹11.08. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Panth Infinity Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Panth Infinity Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.